Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Bradley, Chipps"'
Autor:
Mark C. Liu, Bradley Chipps, Xavier Munoz, Gilles Devouassoux, Miguel Bergna, Steven G. Smith, Robert G. Price, Dmitry V. Galkin, Jay Azmi, Dalal Mouneimne, Frank C. Albers, Kenneth R. Chapman
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background The OSMO study assessed the efficacy of switching to mepolizumab in patients with severe eosinophilic asthma that was uncontrolled whilst receiving omalizumab. The objective of this analysis was to assess the proportion of patient
Externí odkaz:
https://doaj.org/article/b4e2e90b44bf489cab4a132a23dc52f2
Autor:
Bradley Chipps, Robert S. Zeiger, David A. Beuther, Joan Reibman, Robert A. Wise, William McCann, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Gale Harding, Katelyn Cutts, Maureen George, Kevin R. Murphy
Publikováno v:
Annals of Allergy, Asthma & Immunology.
Autor:
Bradley Chipps, Alberto Papi, Frank Albers, Mark Cooper, Ileen Gilbert, Carin Jorup, Frank Trudo, Christy Cappelletti, Mark Weinberg
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB16
Autor:
William McCann, Bradley Chipps, David Beuther, Robert Zeiger, Robert Wise, Joan Reibman, Maureen George, Ileen Gilbert, James Eudicone, Hitesh Gandhi, Gale Harding, Katelyn Cutts, Kevin Murphy
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB78
Autor:
Kevin Murphy, Bradley Chipps, David Beuther, William McCann, Robert Wise, Joan Reibman, Maureen George, Ileen Gilbert, James Eudicone, Hitesh Gandhi, Karin Coyne, Melissa Ross, Robert Zeiger
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB78
Autor:
Warner Carr, Bradley Chipps, Reynold Panettieri, Weily Soong, Jennifer Trevor, Donna Carstens, Eduardo Genofre, Chris Ambrose
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB14
Autor:
Michael Blaiss, William Berger, Bradley Chipps, Vivian Hernandez-Trujillo, Wanda Phipatanakul, Keith Steward
Publikováno v:
Allergy Asthma Proc
Background: Ciclesonide (CIC) is an inhaled corticosteroid (ICS) approved for the maintenance treatment of asthma in patients ages ≥ 12 years. The prodrug aspect of CIC is associated with a safety profile that may make it ideal for children. Object
Autor:
David A. Beuther, Kevin R. Murphy, Robert S. Zeiger, Robert A. Wise, William McCann, Joan Reibman, Maureen George, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Melissa Ross, Karin S. Coyne, Bradley Chipps
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 10:3204-3212.e2
The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, equally weighted, yes/no control tool validated in patients with asthma aged 12 years and older.To evaluate AIRQ's ability to predict patient-reported exacerbations over 12 months.Pati
Autor:
Reynold Panettieri, Bradley Chipps, Wendy Moore, Weily Soong, Warner Carr, James Kreindler, Sean O'Quinn, Frank Trudo, Christopher Ambrose
Publikováno v:
Chest. 156:A211-A214
Autor:
Dmitry V Galkin, Bradley Chipps, Miguel Bergna, Dalal Mouneimne, Mark C. Liu, Frank C. Albers, Xavier Muñoz, Gilles Devouassoux, Jay Azmi, Kenneth R. Chapman, Robert Price
Publikováno v:
Allergy
Background Mepolizumab and omalizumab are treatments for distinct but overlapping severe asthma phenotypes. Objective To assess if patients eligible for both biologics but not optimally controlled with omalizumab experience improved asthma control wh